Literature DB >> 19192759

Plateauing oxygen consumption.

Jeffrey B Riley1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19192759      PMCID: PMC4680719     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


× No keyword cloud information.
  8 in total

1.  Oxygen consumption plateauing: a better method of achieving optimum perfusion. 1979.

Authors:  J P Mandl; J R Motley
Journal:  J Extra Corpor Technol       Date:  2008-12

2.  Anaerobic metabolism during cardiopulmonary bypass: predictive value of carbon dioxide derived parameters.

Authors:  Marco Ranucci; Giuseppe Isgrò; Federica Romitti; Sara Mele; Bonizella Biagioli; Pierpaolo Giomarelli
Journal:  Ann Thorac Surg       Date:  2006-06       Impact factor: 4.330

3.  What factors are associated with hyperlactatemia after cardiac surgery characterized by well-maintained oxygen delivery and a normal postoperative course? A retrospective study.

Authors:  S Inoue; M Kuro; H Furuya
Journal:  Eur J Anaesthesiol       Date:  2001-09       Impact factor: 4.330

4.  Relationship of whole body oxygen consumption to perfusion flow rate during hypothermic cardiopulmonary bypass.

Authors:  L S Fox; E H Blackstone; J W Kirklin; R W Stewart; P N Samuelson
Journal:  J Thorac Cardiovasc Surg       Date:  1982-02       Impact factor: 5.209

5.  Oxygen consumption, carbon dioxide production and lactic acid during normothermic cardiopulmonary bypass.

Authors:  M Engoren; M Evans
Journal:  Perfusion       Date:  2000-09       Impact factor: 1.972

Review 6.  What is optimal flow and how to validate this.

Authors:  Filip De Somer
Journal:  J Extra Corpor Technol       Date:  2007-12

7.  A model for cardiopulmonary bypass redesign.

Authors:  R C Groom; D S Likosky; R J Forest; G T O'Connor; J R Morton; C S Ross; C Clark; R Kramer
Journal:  Perfusion       Date:  2004-07       Impact factor: 1.972

8.  Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome.

Authors:  Marco Ranucci; Barbara De Toffol; Giuseppe Isgrò; Federica Romitti; Daniela Conti; Maira Vicentini
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.